Financial Sense Advisors, Inc. Amgen Inc Transaction History

Financial Sense Advisors, Inc.

$323 Million
Q3 2024

A detailed history of Financial Sense Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Financial Sense Advisors, Inc. holds 12,207 shares of AMGN stock, worth $3.21 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares

12,207

Previous 11,767 3.74%

Holding current value

$3.21 Million

Previous $3.68 Million 6.99%

% of portfolio

1.22%

Previous 1.27%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$309.38 - $337.38 $136,127 - $148,447	440 Added 3.74%	12,207 $3.93 Million
Q2 2024 Jul 23, 2024	BUY	$262.75 - $319.31 $33,369 - $40,552	127 Added 1.09%	11,767 $3.68 Million
Q1 2024 Apr 19, 2024	SELL	$268.87 - $324.56 $23,660 - $28,561	-88 Reduced 0.75%	11,640 $3.31 Million
Q4 2023 Jan 12, 2024	BUY	$255.7 - $288.46 $241,125 - $272,017	943 Added 8.74%	11,728 $3.38 Million
Q3 2023 Nov 06, 2023	SELL	$218.65 - $271.46 $706,458 - $877,087	-3,231 Reduced 23.05%	10,785 $2.9 Million
Q2 2023 Aug 02, 2023	SELL	$214.27 - $253.37 $43,068 - $50,927	-201 Reduced 1.41%	14,016 $3.11 Million
Q1 2023 Apr 24, 2023	BUY	$225.79 - $275.2 $1.02 Million - $1.25 Million	4,530 Added 46.76%	14,217 $3.44 Million
Q4 2022 Feb 06, 2023	BUY	$229.03 - $291.01 $470,198 - $597,443	2,053 Added 26.89%	9,687 $2.54 Million
Q3 2022 Oct 13, 2022	SELL	$224.46 - $253.15 $2,020 - $2,278	-9 Reduced 0.12%	7,634 $1.72 Million
Q2 2022 Jul 18, 2022	BUY	$230.71 - $256.74 $1.76 Million - $1.96 Million	7,643 New	7,643 $1.86 Million
Q1 2022 May 05, 2022	SELL	$219.27 - $242.57 $1.69 Million - $1.87 Million	-7,710 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $274,056 - $313,632	1,378 Added 21.76%	7,710 $1.74 Million
Q3 2021 Nov 03, 2021	BUY	$212.27 - $248.7 $451,710 - $529,233	2,128 Added 50.62%	6,332 $1.35 Million
Q2 2021 Jul 29, 2021	BUY	$233.58 - $259.14 $748,390 - $830,284	3,204 Added 320.4%	4,204 $1.03 Million
Q1 2021 Apr 28, 2021	SELL	$221.91 - $258.6 $443 - $517	-2 Reduced 0.2%	1,000 $249,000
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $432 - $515	2 Added 0.2%	1,002 $230,000
Q2 2020 Jul 20, 2020	BUY	$197.81 - $242.74 $197,810 - $242,740	1,000 New	1,000 $236,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Sense Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Sense Advisors, Inc. with notifications on news.

Account

Financial Sense Advisors, Inc. Amgen Inc Transaction History